Amphetamine News and Research

RSS

ADHD medication proves most effective in treating symptoms, new study finds

A comprehensive overview of treatment options available for ADHD for children and adolescent individuals.

27 Mar 2024

Study reveals ADHD medication reduces psychiatric hospitalizations and work disability

Study highlights the benefits and potential risks of ADHD medication, revealing that stimulants like amphetamines and methylphenidate reduce the risk of psychiatric hospitalization and improve long-term employment outcomes, though concerns about adverse effects such as increased heart rate and potential for triggering psychosis or mania remain.

24 Mar 2024

New research sheds light on how GLP-1 obesity drugs may change food cravings

GLP-1 analog treatments potentially alter food preferences and reduce obesity by decreasing appetite and food consumption, with further research needed for long-term weight maintenance using objective measures.

10 Mar 2024

New hope for binge eating and bulimia: GLP-1 drugs could be the key

GLP-1 receptor agonists show promise in reducing binge eating behaviors in disorders like bulimia nervosa, offering a new avenue for treatment with minimal side effects.

4 Mar 2024

Gut bacteria diversity linked to body weight, athletes show healthier profiles

Systematic review reveals gut microbiome variations correlate with body composition changes across lifespan, highlighting differences between obese individuals and athletes.

29 Feb 2024

Restoring brain pathways to fight opioid addiction

Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model.

20 Feb 2024

Patients with narcolepsy face a dual nightmare of medication shortages and stigma

Nina Shand couldn't stay awake. She had taken afternoon naps since she was a teenager to accommodate her "work hard, play hard" attitude, but when she was in her mid-20s the sleepiness became more severe.

3 Jan 2024

Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications

The risk of Attention Deficit/Hyperactivity Disorder (ADHD) among glucose 6-phosphate dehydrogenase (G6PD)-deficient individuals.

1 Dec 2023

Marijuana and hallucinogen use, binge drinking reach highest level among adults 35 to 50

Past-year use of marijuana and hallucinogens by adults 35 to 50 years old continued a long-term upward trajectory to reach all-time highs in 2022, according to the Monitoring the Future (MTF) panel study, an annual survey of substance use behaviors and attitudes of adults 19 to 60 years old.

17 Aug 2023

CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson's disease?

Researchers utilize the CRISPR-Cas9 system to induce the synthesis of dopamine (DA) in the brains of a rat model for Parkinson’s disease.

11 Aug 2023

Study finds high rates of illicit drug use in young adults who experienced sudden cardiac death

Approximately one-third of young adults in Victoria, Australia, who experienced sudden cardiac deaths (SCDs) outside of a hospital setting from April 2019 to April 2021 used illegal drugs prior to their fatal events, reports a new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier.

27 Jul 2023

MDXX drugs: A promising new therapy for autism spectrum disorder

A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).

29 Jun 2023

Study reviews the diagnosis and treatment of acute myocarditis

Scientists have recently reviewed and summarized the evidence regarding diagnosing and treating acute myocarditis.

6 Apr 2023

Hypothalamic inflammation and obesity, study suggests a pathological mechanism

In a recent review published in the European Journal of Endocrinology, researchers discussed current research on the relationship between human obesity and inflammation of the hypothalamus.

14 Mar 2023

Racism contributes to disproportionate newborn drug testing

If a newborn tests positive for certain drugs after birth, mandated reporters in many states – including health care professionals and social workers – are required to report it to Child Protective Services.

8 Mar 2023

New support for a serotonin deficit in depression

Since the 1960s, researchers have postulated that major depression stems from disruptions in the serotonin neurotransmitter system, but the evidence for that idea, though plentiful, was indirect.

16 Dec 2022

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

In a recent study posted to the medRxiv* preprint server, researchers investigated the incidence of cardiac AESIs (adverse events of special interest) among Kaiser Permanente Northwest (KPNW) members who had received JYNNEOS vaccinations against the monkeypox (MPX) virus.

16 Nov 2022

Amphetamine News and Research

ADHD medication proves most effective in treating symptoms, new study finds

Study reveals ADHD medication reduces psychiatric hospitalizations and work disability

New research sheds light on how GLP-1 obesity drugs may change food cravings

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Gut bacteria diversity linked to body weight, athletes show healthier profiles

Restoring brain pathways to fight opioid addiction

Patients with narcolepsy face a dual nightmare of medication shortages and stigma

Study reveals G6PD deficiency linked to higher ADHD risk and increased use of stimulant medications

Marijuana and hallucinogen use, binge drinking reach highest level among adults 35 to 50

CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson's disease?

Study finds high rates of illicit drug use in young adults who experienced sudden cardiac death

MDXX drugs: A promising new therapy for autism spectrum disorder

Study reviews the diagnosis and treatment of acute myocarditis

Hypothalamic inflammation and obesity, study suggests a pathological mechanism

Racism contributes to disproportionate newborn drug testing

New support for a serotonin deficit in depression

Jynneos vaccine for Monkeypox not linked to hospitalization, serious cardiac events

ADHD drug associated with lowest risk of amphetamine-related hospitalizations and death

Researchers identify brain cells responsible for shifts in the sleep-wake rhythm

Eating disorders could be treated by modulating gut microbiota

Forensics And Toxicology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News